Evidence map›Paper›PMID 29995846›Full record

ArticleNature2018

Mechanism of parkin activation by PINK1.

Christina Gladkova, Sarah L Maslen, J Mark Skehel, David Komander

Open access · greenAbstract read
In one paragraph

Article in Nature, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 232 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
232citing papers in PubMed, 1 pooled it
23.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

232 citing papers in PubMed, 1 synthesis or guideline pooled it, 387 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Species-dependent activities of the PINK1-parkin axis.Translational neurodegeneration · 2026
    Review
  6. Review
  7. Molecular mechanisms underlying FCCP-induced mitophagy in human airway smooth muscle cells.American journal of physiology. Lung cellular and molecular physiology · 2026
    Article
  8. Review
  9. Review
  10. Regulation and roles of mammalian mitophagy.Nature reviews. Molecular cell biology · 2026
    Review
  11. AbioRxiv : the preprint server for biology · 2026
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

172 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Christina GladkovaMedical Research Council Laboratory of Molecular Biology, Cambridge, UK.
Sarah L MaslenMedical Research Council Laboratory of Molecular Biology, Cambridge, UK.
J Mark SkehelMedical Research Council Laboratory of Molecular Biology, Cambridge, UK.
David KomanderMedical Research Council Laboratory of Molecular Biology, Cambridge, UK. dk@mrc-lmb.cam.ac.uk.
MRC Laboratory of Molecular Biology · GBMedical Research Council · GB

Funding

European Research Council 309756Medical Research Council MC_U105192732
6 · The paper itself

Abstract

Mutations in the E3 ubiquitin ligase parkin (PARK2, also known as PRKN) and the protein kinase PINK1 (also known as PARK6) are linked to autosomal-recessive juvenile parkinsonism (AR-JP)

Indexed as

Binding SitesDeuterium Exchange MeasurementEnzyme ActivationHumansMass SpectrometryModels, MolecularPhosphorylationProtein DomainsProtein KinasesPTEN-Induced Putative KinaseTumor Suppressor ProteinsUbiquitinationUbiquitin-Protein LigasesUbiquitin ThiolesteraseBAP1 protein, humanparkin proteinProtein KinasesPTEN-Induced Putative KinaseTumor Suppressor ProteinsUbiquitin-Protein LigasesUbiquitin Thiolesterase

Identifiers

PMID29995846
PMCPMC6071873
OpenAlexW2805711807

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.